Real-World Effectiveness and Use of Dupilumab in Eosinophilic Esophagitis
Dupilumab demonstrates effectiveness across EoE severity, including milder disease without previous treatment failure. Improving follow-up and assessing cost-effectiveness will help clarify its role in the treatment algorithm.
Authors
- Michelle Russin (ORCID: https://orcid.org/0009-0008-6100-9945)
- Joy W. Chang (ORCID: https://orcid.org/0000-0001-8319-6042)
- Joel H. Rubenstein (ORCID: https://orcid.org/0000-0001-7189-3254)
- Joan W. Chen (ORCID: https://orcid.org/0000-0001-9425-3209)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Michigan (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.14309/ajg.0000000000003087
- Citations
- 5
- Primary Topic
- Eosinophilic Esophagitis
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases